Full Schedule

07:00 – 08:00 CST

Breakfast Session: Ask an expert
Location: Michigan A/B

Primary Presenter: Elizabeth Torrone, MSPH, PhD (she/her/hers) – CDC

07:00 – 08:00 CST

Breakfast Session: Comprehensive Care for Women with STIs and Vaginitis: The Role of Molecular Diagnostics in Co-Testing to Avoid Missed Diagnoses
Location: Chicago 9

Invited Speaker: Christina A. Muzny, MD, MSPH (she/her/hers) – Division of Infectious Diseases, University of Alabama at Birmingham

07:00 – 08:00 CST

Breakfast Session: Mycoplasma genitalium: Understanding prevalence and clinical management of infection in high-risk populations
Location: Chicago 10

07:00 – 18:00 CST

Design-a-thon: Community Group
Location: Arkansas

07:00 – 18:00 CST

Design-a-thon: Early Career Research Group
Location: Mississippi

07:00 – 18:00 CST

Design-a-thon: Silver Group
Location: Ohio

07:00 – 18:00 CST

Design-a-thon: Traveller Group
Location: Colorado

08:30 – 09:30 CST

Plenary 1: Sexual Health: Trust and Rights
Location: Sheraton Ballroom

Moderator: Patricia Kissinger, BSN, MPH, PhD (she/her/hers) – Tulane University School of Public Health and Tropical Medicine

Moderator: Andrew Winter, PhD (he/him/his) – NHS Greater Glasgow and Clyde

Invited Talk

08:30 – 09:00 CST

PL1.1 - How can we regain trust in science?
Location: Sheraton Ballroom

Invited Speaker: Jeffrey D. Klausner, MD MPH (he/him/his) – Department of Population and Public Health Sciences, University of Southern California

Invited Talk

09:00 – 09:30 CST

PL1.2 - Gender, health inequality and reproductive rights
Location: Sheraton Ballroom

Invited Speaker: Sarah Hawkes, PhD – UCL

Invited Talk

10:00 – 11:30 CST

Vaginal Conditions
Location: Chicago 8

Moderator: Janneke H.H.M van de Wijgert, MD PhD MPH (she/her/hers) – Julius Center of Health Sciences and Primary Care, University Medical Center Utrecht

Moderator: Hilary Reno, MD, PhD – Washington University in St. Louis, School of Medicine

10:00 – 10:15 CST

O1.1 - Bacterial Vaginosis and Spontaneous Clearance of Urogenital Chlamydia trachomatis in the Longitudinal Study of Vaginal Flora
Location: Chicago 8

Primary Presenter: Sarah E. Brown (she/her/hers) – University of Maryland School of Medicine

Epidemiology & Monitoring

10:15 – 10:30 CST

O1.2 - The contribution of the vaginal microbiota to treatment failure following first-line antibiotics for bacterial vaginosis
Location: Chicago 8

Primary Presenter: Erica L. Plummer, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre

Basic & Translational Science

Erica L. Plummer, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre ### 1878824###Primary Presenter###Postdoctoral Research Fellow###Monash University and Melbourne Sexual Health Centre###
Primary Presenter: Erica L. Plummer, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre
### she/her/hers @@@ Amelia Sfameni ### 1978046###Co-author#########
Co-author: Amelia Sfameni
### @@@ Lenka A. Vodstrcil, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre ### 1978041###Co-author###Senior Research Fellow###Monash University and Melbourne Sexual Health Centre###
Co-author: Lenka A. Vodstrcil, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre
### she/her/hers @@@ Jennifer Danielewski – Murdoch Children's Research Institute ### 1978042###Co-author######Murdoch Children's Research Institute###
Co-author: Jennifer Danielewski – Murdoch Children's Research Institute
### @@@ Gerald Murray, PhD – University of Melbourne ### 1978044###Co-author###Senior Research Fellow###University of Melbourne###
Co-author: Gerald Murray, PhD – University of Melbourne
### @@@ Michelle Doyle – Melbourne Sexual Health Centre ### 1978043###Co-author######Melbourne Sexual Health Centre###
Co-author: Michelle Doyle – Melbourne Sexual Health Centre
### @@@ Glenda Fehler – Melbourne Sexual Health Centre ### 1978047###Co-author###Mecical Scientist###Melbourne Sexual Health Centre###
Co-author: Glenda Fehler – Melbourne Sexual Health Centre
### @@@ Christopher K. Fairley – Melbourne Sexual Health Centre, Alfred Health ### 1977878###Co-author######Melbourne Sexual Health Centre, Alfred Health###
Co-author: Christopher K. Fairley – Melbourne Sexual Health Centre, Alfred Health
### @@@ Suzanne M. Garland, MD – University of Melbourne ### 1978045###Co-author###Prof###University of Melbourne###
Co-author: Suzanne M. Garland, MD – University of Melbourne
### @@@ Eric P.F Chow, PhD, MScMed(ClinEpid), MBiostat, MPH, MApplSc (he/him/his) – Monash University ### 1977877###Co-author###Professor###Monash University###
Co-author: Eric P.F Chow, PhD, MScMed(ClinEpid), MBiostat, MPH, MApplSc (he/him/his) – Monash University
### he/him/his @@@ Jane Hocking, BAppSc, MPH, MHlthSc, PhD – University of Melbourne ### 1977882###Co-author###Head, Sexual Health Unit###University of Melbourne###
Co-author: Jane Hocking, BAppSc, MPH, MHlthSc, PhD – University of Melbourne
### @@@ Catriona Bradshaw, MD PHD – Monash University and Melbourne Sexual Health Centre ### 1900420###Co-author###Professor###Monash University and Melbourne Sexual Health Centre###
Co-author: Catriona Bradshaw, MD PHD – Monash University and Melbourne Sexual Health Centre
###

10:30 – 10:45 CST

O1.3 - Increasing rates of non-albicans Candida species and fluconazole resistant Candida albicans in women with recurrent vulvovaginal candidiasis in a UK region
Location: Chicago 8

Primary Presenter: Jennifer CL Ratner, MSc – The Leeds Teaching Hospitals NHS Trust

Clinical Science

10:45 – 11:00 CST

O1.4 - Sexual transmission of urogenital bacteria in heterosexual partners: whole metagenome sequencing evidence from a sexual network study
Location: Chicago 8

Primary Presenter: Kayla A. Carter, PhD, MPH (they/them/theirs) – Institute for Genome Sciences, University of Maryland School of Medicine

Basic & Translational Science

11:00 – 11:15 CST

O1.5 - Secreted Proteases from Bacterial Vaginosis-Associated Bacteria Target Human MMP-8 and Modulate Endocervical Barrier Function
Location: Chicago 8

Primary Presenter: Karen V. Lithgow, PhD – University of Calgary, Canada

Basic & Translational Science

11:15 – 11:30 CST

O1.6 - Spontaneous resolution and treatment outcomes in men with Trichomonas vaginalis infection
Location: Chicago 8

Primary Presenter: Christina A. Muzny, MD, MSPH (she/her/hers) – Division of Infectious Diseases, University of Alabama at Birmingham

Clinical Science

10:00 – 11:30 CST

Reaching the vulnerable
Location: Chicago 9

Moderator: Abigail Norris Turner, PhD – Ohio State University

Moderator: Aneeka Ratnyake

10:00 – 10:15 CST

O2.1 - Calculating the value of behavioural science and community engagement in promoting vaccination of MSM: a transmission-dynamic health-economic analysis of 4CMenB (Bexsero) vs gonorrhoea as an example
Location: Chicago 9

Primary Presenter: Peter J. White, PhD – Imperial College London

Co-Author: Dariya Nikitin, MSc, MRes – MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London

Policy & Community Engagement

10:15 – 10:30 CST

O2.2 - Relationships and risk: A mixed-methods study of perceptions and management of STI/HIV risk among heterosexual-identifying men who have sex with both men and women
Location: Chicago 9

Primary Presenter: Tyrone J. Curtis, MSc, PhD (he/him/his) – University of Victoria

Behavioral & Social Science

10:30 – 10:45 CST

O2.3 - “It’s not safe for me and what would it achieve?” Acceptability of patient referral partner notification for sexually transmitted infections to adolescents and young people in Zimbabwe
Location: Chicago 9

Primary Presenter: Chido Dziva Chikwari, PhD (she/her/hers) – London School of Hygiene & Tropical Medicine

Implementation Science

Chido Dziva Chikwari, PhD (she/her/hers) – London School of Hygiene & Tropical Medicine ### 1977914###Primary Presenter###Assistant Professor###London School of Hygiene & Tropical Medicine###
Primary Presenter: Chido Dziva Chikwari, PhD (she/her/hers) – London School of Hygiene & Tropical Medicine
### she/her/hers @@@ Joni Lariat – University of Sydney ### 1978258###Co-author######University of Sydney###
Co-author: Joni Lariat – University of Sydney
### @@@ Ethel Dauya, BSC, MPH – Biomedical Research and Training Institute ### 1977909###Co-author###Ms###Biomedical Research and Training Institute###
Co-author: Ethel Dauya, BSC, MPH – Biomedical Research and Training Institute
### @@@ Valentine bamu – Biomedical Research and Training Institute ### 1978263###Co-author######Biomedical Research and Training Institute###
Co-author: Valentine bamu – Biomedical Research and Training Institute
### @@@ Victor Kaisi – Biomedical Research and Training Institute ### 1978264###Co-author######Biomedical Research and Training Institute###
Co-author: Victor Kaisi – Biomedical Research and Training Institute
### @@@ Laura Kafata – Biomedical Research and Training Institute ### 1978265###Co-author######Biomedical Research and Training Institute###
Co-author: Laura Kafata – Biomedical Research and Training Institute
### @@@ Esnath Meza – Biomedical Research and Training Institute ### 1978266###Co-author######Biomedical Research and Training Institute###
Co-author: Esnath Meza – Biomedical Research and Training Institute
### @@@ Anna Machiha, BSc (she/her/hers) – Ministry of Health and Child Care ### 1977912###Co-author###National STI Prevention and Condom Coordinator###Ministry of Health and Child Care###
Co-author: Anna Machiha, BSc (she/her/hers) – Ministry of Health and Child Care
### she/her/hers @@@ Tsitsi Bandason – Biomedical Research and Training Institute ### 1977911###Co-author######Biomedical Research and Training Institute###
Co-author: Tsitsi Bandason – Biomedical Research and Training Institute
### @@@ Constance Mackworth-Young – London School of Hygiene and Tropical Medicine ### 1978267###Co-author###Assistant Professor###London School of Hygiene and Tropical Medicine###
Co-author: Constance Mackworth-Young – London School of Hygiene and Tropical Medicine
### @@@ Suzanna Francis – London School of Hygiene and Tropical Medicine ### 1978268###Co-author######London School of Hygiene and Tropical Medicine###
Co-author: Suzanna Francis – London School of Hygiene and Tropical Medicine
### @@@ Rashida A. Ferrand, MD, PhD – London School of Hygiene and Tropical Medicine ### 1977913###Co-author###Professor###London School of Hygiene and Tropical Medicine###
Co-author: Rashida A. Ferrand, MD, PhD – London School of Hygiene and Tropical Medicine
### @@@ Sarah Bernays – University of Sydney ### 1978269###Co-author######University of Sydney###
Co-author: Sarah Bernays – University of Sydney
###

10:45 – 11:00 CST

O2.4 - Preparedness of pregnant women to wait for same-day results of sexually transmitted infections
Location: Chicago 9

Primary Presenter: Ranjana M S Gigi, MMed, PhD student – 1) Institute of Social and Preventive Medicine, University of Bern, Switzerland 2) Research Unit, Foundation for Professional Development, South Africa

Implementation Science

Ranjana M S Gigi, MMed, PhD student – 1) Institute of Social and Preventive Medicine, University of Bern, Switzerland 2) Research Unit, Foundation for Professional Development, South Africa ### 1978329###Primary Presenter###MD-PhD student###1) Institute of Social and Preventive Medicine, University of Bern, Switzerland 2) Research Unit, Foundation for Professional Development, South Africa###
Primary Presenter: Ranjana M S Gigi, MMed, PhD student – 1) Institute of Social and Preventive Medicine, University of Bern, Switzerland 2) Research Unit, Foundation for Professional Development, South Africa
### @@@ Mandisa Mildred Mdingi, MSc (she/her/hers) – Foundation for Professional Development ### 1978328###Co-author###Research Project Manager###Foundation for Professional Development###
Co-author: Mandisa Mildred Mdingi, MSc (she/her/hers) – Foundation for Professional Development
### she/her/hers @@@ Christina A. Muzny, MD, MSPH (she/her/hers) – Division of Infectious Diseases, University of Alabama at Birmingham ### 1678449###Co-author###Associate Professor of Medicine, Epidemiology, and Obstetrics & Gynecology###Division of Infectious Diseases, University of Alabama at Birmingham###
Co-author: Christina A. Muzny, MD, MSPH (she/her/hers) – Division of Infectious Diseases, University of Alabama at Birmingham
### she/her/hers @@@ Christopher M. Taylor, PhD – Department of Microbiology, Immunology, and Parasitology, Louisiana Health Sciences Center New Orleans ### 1978295###Co-author######Department of Microbiology, Immunology, and Parasitology, Louisiana Health Sciences Center New Orleans###
Co-author: Christopher M. Taylor, PhD – Department of Microbiology, Immunology, and Parasitology, Louisiana Health Sciences Center New Orleans
### @@@ Chibuzor M. Babalola, MD, MPH – Keck School of Medicine Department of Population and Public Health Sciences, University of Southern California ### 1978132###Co-author###Postdoctoral Research Associate & Part-time Professor###Keck School of Medicine Department of Population and Public Health Sciences, University of Southern California###
Co-author: Chibuzor M. Babalola, MD, MPH – Keck School of Medicine Department of Population and Public Health Sciences, University of Southern California
### @@@ Andrew Medina-Marino – Desmond Tutu Health Foundation, South Africa ### 1978484###Co-author######Desmond Tutu Health Foundation, South Africa###
Co-author: Andrew Medina-Marino – Desmond Tutu Health Foundation, South Africa
### @@@ Jeffrey D. Klausner, MD MPH (he/him/his) – Department of Population and Public Health Sciences, University of Southern California ### 1878781###Co-author###Clinical Professor###Department of Population and Public Health Sciences, University of Southern California###
Co-author: Jeffrey D. Klausner, MD MPH (he/him/his) – Department of Population and Public Health Sciences, University of Southern California
### he/him/his @@@ Remco Peters, MD, PhD (he/him/his) – Foundation for Professional Development ### 1878825###Co-author###Head of Clinical Research###Foundation for Professional Development###
Co-author: Remco Peters, MD, PhD (he/him/his) – Foundation for Professional Development
### he/him/his @@@ Nicola Low, MD (she/her/hers) – University of Bern ### 1878795###Co-author###Professor of Epidemiology and Public Health###University of Bern###
Co-author: Nicola Low, MD (she/her/hers) – University of Bern
### she/her/hers

11:00 – 11:15 CST

O2.5 - Mixed methods analysis of network structures, support exchanged, and communication patterns within the social networks of transgender women in Lima, Peru
Location: Chicago 10

Primary Presenter: Cherie S Blair, MD, PhD – Department of Medicine, David Geffen School of Medicine at UCLA, Division of Infectious Diseases, Los Angeles, CA, USA

Co-Author: Tijana Temelkovska, n/a – David Geffen School of Medicine at UCLA, Los Angeles, CA

Behavioral & Social Science

Cherie S Blair, MD, PhD – Department of Medicine, David Geffen School of Medicine at UCLA, Division of Infectious Diseases, Los Angeles, CA, USA ### 1978300###Primary Presenter###Assistant Professor of Medicine###Department of Medicine, David Geffen School of Medicine at UCLA, Division of Infectious Diseases, Los Angeles, CA, USA###
Primary Presenter: Cherie S Blair, MD, PhD – Department of Medicine, David Geffen School of Medicine at UCLA, Division of Infectious Diseases, Los Angeles, CA, USA
### @@@ Tijana Temelkovska, n/a – David Geffen School of Medicine at UCLA, Los Angeles, CA ### 1978499### Co-Author######David Geffen School of Medicine at UCLA, Los Angeles, CA###
Co-Author: Tijana Temelkovska, n/a – David Geffen School of Medicine at UCLA, Los Angeles, CA
### @@@ Kathleen Moriarty – Medstar Georgetown University Hospital, Washington D.C., USA ### 1978500###Co-author######Medstar Georgetown University Hospital, Washington D.C., USA###
Co-author: Kathleen Moriarty – Medstar Georgetown University Hospital, Washington D.C., USA
### @@@ Leyla Huerta – Féminas Perú, Lima, Perú ### 1978501###Co-author######Féminas Perú, Lima, Perú###
Co-author: Leyla Huerta – Féminas Perú, Lima, Perú
### @@@ Amaya Perez-Brumer – Division of Social and Behavioral Health Sciences, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada ### 1978502###Co-author######Division of Social and Behavioral Health Sciences, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada###
Co-author: Amaya Perez-Brumer – Division of Social and Behavioral Health Sciences, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
### @@@ Eddy R Segura – David Geffen School of Medicine at UCLA, Los Angeles, CA ### 1978297###Co-author######David Geffen School of Medicine at UCLA, Los Angeles, CA###
Co-author: Eddy R Segura – David Geffen School of Medicine at UCLA, Los Angeles, CA
### @@@ Ryan Colby Passaro – Department of Emergency Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, CA ### 1978503###Co-author######Department of Emergency Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, CA###
Co-author: Ryan Colby Passaro – Department of Emergency Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, CA
### @@@ Jordan E Lake – Department of Internal Medicine, McGovern Medical School at UTHealth, Houston, Texas ### 1978298###Co-author######Department of Internal Medicine, McGovern Medical School at UTHealth, Houston, Texas###
Co-author: Jordan E Lake – Department of Internal Medicine, McGovern Medical School at UTHealth, Houston, Texas
### @@@ Jesse L Clark – Department of Medicine, David Geffen School of Medicine at UCLA, Division of Infectious Diseases, Los Angeles, CA, USA ### 1978299###Co-author######Department of Medicine, David Geffen School of Medicine at UCLA, Division of Infectious Diseases, Los Angeles, CA, USA###
Co-author: Jesse L Clark – Department of Medicine, David Geffen School of Medicine at UCLA, Division of Infectious Diseases, Los Angeles, CA, USA
###

11:15 – 11:30 CST

O2.6 - Community-based integrated HIV and sexual and reproductive health services: why did we miss young men and what is it going to take to reach them?
Location: Chicago 9

Primary Presenter: Constancia Mavodza, PhD (she/her/hers) – Biomedical Research and Training Institute

Implementation Science

Constancia Mavodza, PhD (she/her/hers) – Biomedical Research and Training Institute ### 1978439###Primary Presenter###Post-doctoral Research Fellow###Biomedical Research and Training Institute###
Primary Presenter: Constancia Mavodza, PhD (she/her/hers) – Biomedical Research and Training Institute
### she/her/hers @@@ Constance Mackworth-Young – London School of Hygiene and Tropical Medicine ### 1978267###Co-author###Assistant Professor###London School of Hygiene and Tropical Medicine###
Co-author: Constance Mackworth-Young – London School of Hygiene and Tropical Medicine
### @@@ Rangarirai Nyamwanza – Biomedical Research and Training Institute ### 1978440###Co-author######Biomedical Research and Training Institute###
Co-author: Rangarirai Nyamwanza – Biomedical Research and Training Institute
### @@@ Portia Nzombe – Biomedical Research and Training Institute ### 1978441###Co-author######Biomedical Research and Training Institute###
Co-author: Portia Nzombe – Biomedical Research and Training Institute
### @@@ Ethel Dauya, BSC, MPH – Biomedical Research and Training Institute ### 1977909###Co-author###Ms###Biomedical Research and Training Institute###
Co-author: Ethel Dauya, BSC, MPH – Biomedical Research and Training Institute
### @@@ Chido Dziva Chikwari, PhD (she/her/hers) – London School of Hygiene & Tropical Medicine ### 1977914###Co-author###Assistant Professor###London School of Hygiene & Tropical Medicine###
Co-author: Chido Dziva Chikwari, PhD (she/her/hers) – London School of Hygiene & Tropical Medicine
### she/her/hers @@@ Mandikudza Tembo – Biomedical Research and Training Institute ### 1978442###Co-author######Biomedical Research and Training Institute###
Co-author: Mandikudza Tembo – Biomedical Research and Training Institute
### @@@ Victoria Simms, PhD (she/her/hers) – London School of Hygiene & Tropical Medicine ### 1977910###Co-author###Associate Professor###London School of Hygiene & Tropical Medicine###
Co-author: Victoria Simms, PhD (she/her/hers) – London School of Hygiene & Tropical Medicine
### she/her/hers @@@ Owen Mugurungi – Ministry of Health and Child Care ### 1978443###Co-author######Ministry of Health and Child Care###
Co-author: Owen Mugurungi – Ministry of Health and Child Care
### @@@ Tsitsi Apollo – Ministry of Health and Child Care ### 1978444###Co-author######Ministry of Health and Child Care###
Co-author: Tsitsi Apollo – Ministry of Health and Child Care
### @@@ Rashida A. Ferrand, MD, PhD – London School of Hygiene and Tropical Medicine ### 1977913###Co-author###Professor###London School of Hygiene and Tropical Medicine###
Co-author: Rashida A. Ferrand, MD, PhD – London School of Hygiene and Tropical Medicine
### @@@ Sarah Bernays – University of Sydney ### 1978269###Co-author######University of Sydney###
Co-author: Sarah Bernays – University of Sydney
###

10:00 – 11:30 CST

Syphilis: Epidemiology and Clinical
Location: Chicago 10

Moderator: Jane Rowley – World Health Organization

Moderator: Susan Tuddenham, MD, MPH – Johns Hopkins University School of Medicine - Division of Infectious DIseases

10:00 – 10:15 CST

O3.1 - Evaluating the clinical features of reported breakthrough cases of congenital syphilis — United States, 2016–2020
Location: Chicago 10

Primary Presenter: Kevin P. O'Callaghan, MB BCh BAO (he/him/his) – Centers for Disease Control and Prevention

Epidemiology & Monitoring

10:15 – 10:30 CST

O3.2 - Rates of reported primary and secondary syphilis among men who have sex with men compared to men who have sex with women only and women who have sex with men in 37 US states, 2018
Location: Chicago 10

Primary Presenter: Jeremy A. Grey, PhD (he/him/his) – CDC

Epidemiology & Monitoring

10:30 – 10:45 CST

O3.3 - Detection of Treponema pallidum at asymptomatic oral, anal and vaginal sites in men and women reporting contact with syphilis.
Location: Chicago 10

Primary Presenter: Ei T. Aung, MBChB (she/her/hers) – Melbourne Sexual Health Centre, The Alfred Health , Melbourne, Victoria

Clinical Science

10:45 – 11:00 CST

O3.4 - Evolutionary insights into syphilis epidemiology - applying Treponema pallidum genomics in high- and low-income settings
Location: Chicago 10

Primary Presenter: Mathew A. Beale, PhD – Wellcome Sanger Institute

Basic & Translational Science

11:00 – 11:15 CST

O3.5 - Temporal Trends in HIV Status by Race/Ethnicity Among Reported Primary and Secondary Syphilis Cases Among Gay, Bisexual, and Other Men who have sex with Men — United States, 2011–2020
Location: Chicago 10

Primary Presenter: Sarah Wondmeneh, MD, MPH – Centers for Disease Control and Prevention

Epidemiology & Monitoring

11:15 – 11:30 CST

O3.6 - Rapid Plasma Reagin (RPR) sero-reversion after treatment and its association with Prior Treponema Pallidum infection: analysis from the PICASSO cohort among people with early syphilis in Peru
Location: Chicago 10

Primary Presenter: Edward Michael Reyes-Diaz, Sr., MD, Ms(c) (he/him/his) – Centro de Investigación Interdisciplinaria en Sexualidad, SIDA y Sociedad, Universidad Peruana Cayetano Heredia

Clinical Science

Edward Michael Reyes-Diaz, Sr., MD, Ms(c) (he/him/his) – Centro de Investigación Interdisciplinaria en Sexualidad, SIDA y Sociedad, Universidad Peruana Cayetano Heredia ### 1977999###Primary Presenter###Researcher###Centro de Investigación Interdisciplinaria en Sexualidad, SIDA y Sociedad, Universidad Peruana Cayetano Heredia###
Primary Presenter: Edward Michael Reyes-Diaz, Sr., MD, Ms(c) (he/him/his) – Centro de Investigación Interdisciplinaria en Sexualidad, SIDA y Sociedad, Universidad Peruana Cayetano Heredia
### he/him/his @@@ Kelika A. Konda, PhD – Department of Population and Public Health Sciences, University of Southern California ### 1978063###Co-author###Associate Professor###Department of Population and Public Health Sciences, University of Southern California###
Co-author: Kelika A. Konda, PhD – Department of Population and Public Health Sciences, University of Southern California
### @@@ Silver K. Vargas, MsC (he/him/his) – Center for Interdisciplinary Studies in Sexuality, AIDS, and Society, Universidad Peruana Cayetano Heredia ### 1977998###Co-author###Coordinator, Laboratory of Sexual Health###Center for Interdisciplinary Studies in Sexuality, AIDS, and Society, Universidad Peruana Cayetano Heredia###
Co-author: Silver K. Vargas, MsC (he/him/his) – Center for Interdisciplinary Studies in Sexuality, AIDS, and Society, Universidad Peruana Cayetano Heredia
### he/him/his @@@ Carlos F, Caceres, MD, PhD – Universidad Peruana Cayetano Heredia ### 1978000###Co-author###Professor###Universidad Peruana Cayetano Heredia###
Co-author: Carlos F, Caceres, MD, PhD – Universidad Peruana Cayetano Heredia
### @@@ Jeffrey D. Klausner, MD MPH (he/him/his) – Department of Population and Public Health Sciences, University of Southern California ### 1878781###Co-author###Clinical Professor###Department of Population and Public Health Sciences, University of Southern California###
Co-author: Jeffrey D. Klausner, MD MPH (he/him/his) – Department of Population and Public Health Sciences, University of Southern California
### he/him/his

10:00 – 11:30 CST

Innovations in STI Care
Location: Sheraton Ballroom

Moderator: Catherine Mathews, PhD (she/her/hers) – South African Medical Research Council

Moderator: Emma M. Harding-Esch, MPhil MSc PhD (she/her/hers) – London School of Hygiene & Tropical Medicine

Invited Talk

10:05 – 10:25 CST

SP1.1 - How to maximise potential of point-of-care tests & decentralised testing
Location: Sheraton Ballroom

Invited Speaker: Teodora Wi – World Health Organization

Invited Talk

10:25 – 10:45 CST

SP1.2 - How much could automated health care replace clinicians?
Location: Sheraton Ballroom

Invited Speaker: Claudia S. Estcourt, MBBS Hons MD FRCP FAChSHM (she/her/hers) – School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK

Invited Talk

10:45 – 11:05 CST

SP1.3 - Social innovation and STI care
Location: Sheraton Ballroom

Invited Speaker: Joseph D. Tucker – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK

Invited Talk

10:00 – 11:30 CST

Tackling stigma, strengthening communities
Location: Chicago 6

Moderator: Adele S. Benzaken – University of Brasília / Oswaldo Cruz Foundation (Instituto Leonidas & Maria Deane)

Moderator: Jacky M. Jennings, PhD, MPH (she/her/hers) – Johns Hopkins School of Medicine

Invited Talk

10:05 – 10:25 CST

SY1.1 - STIs: the risk of stigmatising stigma
Location: Chicago 6

Invited Speaker: Jorge Saavedra, MD MPH MSc (he/him/his) – AHF GLOBAL PUBLIC HEALTH INSTITUTE

Invited Talk

10:25 – 10:45 CST

SY1.2 - Decriminalization of same-sex relations and social attitudes
Location: Chicago 6

Invited Speaker: Weiming Tang – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

Invited Talk

10:45 – 11:05 CST

SY1.3 - The Longest Mile: Stigma’s impact on sexual health for women in the Southern US
Location: Chicago 6

Invited Speaker: Latesha Elopre, MD, MSPH – University of Alabama at Birmingham, School of Medicine, Division of Infectious Diseases

Invited Talk

10:00 – 11:30 CST

Worldwide strategies against antimicrobial resistance
Location: Chicago 7

Moderator: Tania Crucitti, PhD (she/her/hers) – Institut Pasteur de Madagascar

Moderator: Magnus Unemo, PhD (he/him/his) – Örebro University

Invited Talk

10:05 – 10:10 CST

SY2.1 - Setting the scene: STI treatment options are running out due to AMR
Location: Chicago 7

Invited Speaker: Magnus Unemo, PhD (he/him/his) – Örebro University

Invited Talk

10:10 – 10:30 CST

SY2.2 - Molecular resistance prediction and resistance-guided STI therapy - when and how to use
Location: Chicago 7

Invited Speaker: Catriona Bradshaw, MD PHD – Monash University and Melbourne Sexual Health Centre

Invited Talk

10:30 – 10:50 CST

SY2.3 - Future treatments for STIs
Location: Chicago 7

Invited Speaker: Lindley Barbee, MD, MPH – University of Washington

Invited Talk

10:50 – 11:05 CST

SY2.4 - Doxycycline PrEP and PEP - impact on microbiome and antimicrobial resistance
Location: Chicago 7

Invited Speaker: Fabian Yuh Shiong Kong, BPharm,MEpi, PhD (he/him/his) – The University of Melbourne

Invited Talk

11:05 – 11:25 CST

SY2.5 - Optimising STI treatment using pharmacodynamics
Location: Chicago 7

Invited Speaker: Magnus Unemo, PhD (he/him/his) – Örebro University

Invited Talk

11:30 – 13:00 CST

Advocacy Zone
Location: Exhibit Hall

11:30 – 13:00 CST

Lunch Session: The importance of meeting underserved women where they are (Lunch is only available to session attendees)
Location: Sheraton Ballroom

13:00 – 14:00 CST

Plenary 2: Sexual Health and Sexual Pleasure
Location: Sheraton Ballroom

Moderator: Lynn Barclay

Invited Talk

13:00 – 13:30 CST

PL2.1 - Putting pleasure back into sexual health - 1
Location: Sheraton Ballroom

Invited Speaker: Keosha T. Bond, EdD, MPH, CHES (she/her/hers) – CUNY School of Medicine

Invited Talk

13:30 – 14:00 CST

PL2.2 - Putting pleasure back into sexual health - 2
Location: Sheraton Ballroom

Invited Speaker: Sandrine Atallah, MD, FECSM, ECPS (she/her/hers) – AUBMC

Invited Talk

14:30 – 16:00 CST

Optimizing urethritis treatment – M. genitalium and pathogens of idiopathic urethritis
Location: Chicago 8

Moderator: Teresa Batteiger, MD MS (she/her/hers) – Indiana University School of Medicine

Moderator: Jørgen Jensen – Statens Serum Institut

14:30 – 14:45 CST

O4.1 - Exploring current etiologies of urethritis: associations of urethral microorganisms and urethritis among men attending 6 STD clinics in the US, 2017-2018
Location: Chicago 8

Primary Presenter: Emily Learner, PhD MPH – Division of STD Prevention, Centers for Disease Control and Prevention

Epidemiology & Monitoring

Emily Learner, PhD MPH – Division of STD Prevention, Centers for Disease Control and Prevention ### 1878821###Primary Presenter###Lead, Epidemiology Research Team###Division of STD Prevention, Centers for Disease Control and Prevention###
Primary Presenter: Emily Learner, PhD MPH – Division of STD Prevention, Centers for Disease Control and Prevention
### @@@ Laura H. Bachmann, MD, MPH (she/her/hers) – Centers for Disease Control/DSTDP ### 1878830###Co-author###Chief Medical Officer###Centers for Disease Control/DSTDP###
Co-author: Laura H. Bachmann, MD, MPH (she/her/hers) – Centers for Disease Control/DSTDP
### she/her/hers @@@ William M. Geisler, MD, MPH (he/him/his) – University of Alabama at Birmingham ### 1978023###Co-author###Professor###University of Alabama at Birmingham###
Co-author: William M. Geisler, MD, MPH (he/him/his) – University of Alabama at Birmingham
### he/him/his @@@ Harold Wiesenfeld – UPMC ### 1978024###Co-author######UPMC###
Co-author: Harold Wiesenfeld – UPMC
### @@@ Lisa E. Manhart, MPH, PhD (she/her/hers) – University of Washington ### 1978025###Co-author###Professor of Epidemiology###University of Washington###
Co-author: Lisa E. Manhart, MPH, PhD (she/her/hers) – University of Washington
### she/her/hers @@@ Stephanie Taylor – Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center ### 1978026###Co-author###Professor of Medicine & Microbiology###Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center###
Co-author: Stephanie Taylor – Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center
### @@@ Arlene C. Seña, MD, MPH – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1978027###Co-author###Professor of Medicine###Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Co-author: Arlene C. Seña, MD, MPH – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
### @@@ Candice J. McNeil, MD, MPH – Wake Forest University School of Medicine ### 1977871###Co-author###Associate Professor###Wake Forest University School of Medicine###
Co-author: Candice J. McNeil, MD, MPH – Wake Forest University School of Medicine
### @@@ Noelle Myler – FHI360 ### 1978028###Co-author######FHI360###
Co-author: Noelle Myler – FHI360
### @@@ Ellen Kersh, PhD, MS – CDC ### 1977996###Co-author###STD Laboratory Branch Chief###CDC###
Co-author: Ellen Kersh, PhD, MS – CDC
### @@@ Robert D. Kirkcaldy, MD, MPH – Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention ### 1977942###Co-author###Associate Director for Science###Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention###
Co-author: Robert D. Kirkcaldy, MD, MPH – Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention
### @@@ MAGNUM Laboratory Working Group – Centers for Disease Control and Prevention ### 1978064###Co-author######Centers for Disease Control and Prevention###
Co-author: MAGNUM Laboratory Working Group – Centers for Disease Control and Prevention
###

14:45 – 15:00 CST

O4.2 - gyrA mutations in Mycoplasma genitalium contribute to moxifloxacin failure – a new target for resistance-guided therapy
Location: Chicago 8

Primary Presenter: Gerald Murray, PhD – University of Melbourne

Basic & Translational Science

Gerald Murray, PhD – University of Melbourne ### 1978044###Primary Presenter###Senior Research Fellow###University of Melbourne###
Primary Presenter: Gerald Murray, PhD – University of Melbourne
### @@@ Erica L. Plummer, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre ### 1878824###Co-author###Postdoctoral Research Fellow###Monash University and Melbourne Sexual Health Centre###
Co-author: Erica L. Plummer, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre
### she/her/hers @@@ Kaveesha Bodihabadu – Kirby Institute ### 1978150###Co-author######Kirby Institute###
Co-author: Kaveesha Bodihabadu – Kirby Institute
### @@@ Jose Torres – University of Melbourne ### 1978152###Co-author######University of Melbourne###
Co-author: Jose Torres – University of Melbourne
### @@@ Teck-Phui Chua – University of Melbourne ### 1978154###Co-author###PhD student###University of Melbourne###
Co-author: Teck-Phui Chua – University of Melbourne
### @@@ Dorothy Machalek – Kirby Institute ### 1978155###Co-author######Kirby Institute###
Co-author: Dorothy Machalek – Kirby Institute
### @@@ Suzanne M. Garland, MD – University of Melbourne ### 1978045###Co-author###Prof###University of Melbourne###
Co-author: Suzanne M. Garland, MD – University of Melbourne
### @@@ Michelle Doyle – Melbourne Sexual Health Centre ### 1978043###Co-author######Melbourne Sexual Health Centre###
Co-author: Michelle Doyle – Melbourne Sexual Health Centre
### @@@ Emma L. Sweeney, PhD – The University of Queensland ### 1978076###Co-author###Postdoctoral Researcher###The University of Queensland###
Co-author: Emma L. Sweeney, PhD – The University of Queensland
### @@@ David Whiley – The University of Queensland ### 1978077###Co-author######The University of Queensland###
Co-author: David Whiley – The University of Queensland
### @@@ Catriona Bradshaw, MD PHD – Monash University and Melbourne Sexual Health Centre ### 1900420###Co-author###Professor###Monash University and Melbourne Sexual Health Centre###
Co-author: Catriona Bradshaw, MD PHD – Monash University and Melbourne Sexual Health Centre
###

15:00 – 15:15 CST

O4.3 - MgSeq: Enabling M. genitalium identification and antimicrobial resistance detection in genital and extra-genital samples from female sex workers in Ecuador using multiplex PCR and nanopore sequencing
Location: Chicago 8

Primary Presenter: Claire Broad (she/her/hers) – St George's, University of London

Basic & Translational Science

15:15 – 15:30 CST

O4.4 - Mycoplasma genitalium Surveillance Data from 2020-2022: Results from the Mycoplasma genitalium in the US (MyGeniUS) Project
Location: Chicago 8

Primary Presenter: Lisa E. Manhart, MPH, PhD – University of Washington

Epidemiology & Monitoring

Lisa E. Manhart, MPH, PhD – University of Washington ### 1978025###Primary Presenter###Professor of Epidemiology###University of Washington###
Primary Presenter: Lisa E. Manhart, MPH, PhD – University of Washington
### @@@ William M. Geisler, MD, MPH – University of Alabama at Birmingham ### 1978023###Co-author###Professor###University of Alabama at Birmingham###
Co-author: William M. Geisler, MD, MPH – University of Alabama at Birmingham
### @@@ Stephen J. Jordan, MD, PhD – Indiana University ### 1978390###Co-author######Indiana University###
Co-author: Stephen J. Jordan, MD, PhD – Indiana University
### @@@ Candice J. McNeil, MD, MPH – Wake Forest University School of Medicine ### 1977871###Co-author###Associate Professor###Wake Forest University School of Medicine###
Co-author: Candice J. McNeil, MD, MPH – Wake Forest University School of Medicine
### @@@ Preeti Pathela – New York City Department of Health and Mental Hygiene ### 1978391###Co-author######New York City Department of Health and Mental Hygiene###
Co-author: Preeti Pathela – New York City Department of Health and Mental Hygiene
### @@@ Hilary Reno, MD, PhD – Washington University in St. Louis, School of Medicine ### 1977873###Co-author###Professor, Division of Infectious Diseases###Washington University in St. Louis, School of Medicine###
Co-author: Hilary Reno, MD, PhD – Washington University in St. Louis, School of Medicine
### @@@ Karen A. Wendel, MD – Denver Health ### 1977874###Co-author###Director STI/HIV Prevention###Denver Health###
Co-author: Karen A. Wendel, MD – Denver Health
### @@@ Olusegun O. Soge, MSc, PhD – University of Washington ### 1977934###Co-author###Assistant Professor###University of Washington###
Co-author: Olusegun O. Soge, MSc, PhD – University of Washington
### @@@ Gina Leipertz – Washington State University ### 1978392###Co-author######Washington State University###
Co-author: Gina Leipertz – Washington State University
### @@@ Anika Parker – University of Washington ### 1978393###Co-author######University of Washington###
Co-author: Anika Parker – University of Washington
### @@@ Damon Getman – Hologic, Inc. ### 1978394###Co-author######Hologic, Inc.###
Co-author: Damon Getman – Hologic, Inc.
### @@@ Matthew R. Golden, MD, MPH – University of Washington ### 1978294###Co-author###Professor###University of Washington###
Co-author: Matthew R. Golden, MD, MPH – University of Washington
###

15:30 – 15:45 CST

O4.5 - Efficacy of minocycline for the treatment of Mycoplasma genitalium
Location: Chicago 8

Primary Presenter: Lenka A. Vodstrcil, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre

Clinical Science

Lenka A. Vodstrcil, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre ### 1978041###Primary Presenter###Senior Research Fellow###Monash University and Melbourne Sexual Health Centre###
Primary Presenter: Lenka A. Vodstrcil, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre
### she/her/hers @@@ Emily Clarke – Melbourne Sexual Health Centre, Alfred Health ### 1978195###Co-author######Melbourne Sexual Health Centre, Alfred Health###
Co-author: Emily Clarke – Melbourne Sexual Health Centre, Alfred Health
### @@@ Erica L. Plummer, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre ### 1878824###Co-author###Postdoctoral Research Fellow###Monash University and Melbourne Sexual Health Centre###
Co-author: Erica L. Plummer, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre
### she/her/hers @@@ Ivette Aguirre – Alfred Health ### 1978194###Co-author######Alfred Health###
Co-author: Ivette Aguirre – Alfred Health
### @@@ Ranjit S Samra, MBChB, MSc, MPH (MSc) – Melbourne Sexual Health Centre, Alfred Health ### 1977890###Co-author###Sexual Health Registrar###Melbourne Sexual Health Centre, Alfred Health###
Co-author: Ranjit S Samra, MBChB, MSc, MPH (MSc) – Melbourne Sexual Health Centre, Alfred Health
### @@@ Christopher K. Fairley – Melbourne Sexual Health Centre, Alfred Health ### 1977878###Co-author######Melbourne Sexual Health Centre, Alfred Health###
Co-author: Christopher K. Fairley – Melbourne Sexual Health Centre, Alfred Health
### @@@ Eric P.F Chow, PhD, MScMed(ClinEpid), MBiostat, MPH, MApplSc (he/him/his) – Monash University ### 1977877###Co-author###Professor###Monash University###
Co-author: Eric P.F Chow, PhD, MScMed(ClinEpid), MBiostat, MPH, MApplSc (he/him/his) – Monash University
### he/him/his @@@ Catriona Bradshaw, MD PHD – Monash University and Melbourne Sexual Health Centre ### 1900420###Co-author###Professor###Monash University and Melbourne Sexual Health Centre###
Co-author: Catriona Bradshaw, MD PHD – Monash University and Melbourne Sexual Health Centre
###

15:45 – 16:00 CST

O4.6 - Idiopathic nongonococcal urethritis may be due to emerging and spontaneously cleared pathogens
Location: Chicago 8

Primary Presenter: David E. Nelson, PhD – Indiana University Schol of Medicine

Basic & Translational Science

14:30 – 16:00 CST

HIV PrEP, Viral STIs
Location: Chicago 9

Moderator: Bill Miller

Moderator: Charlie Peterson (he/him/his) – University of Illinois at Chicago (UIC)

14:30 – 14:45 CST

O5.1 - PrEP Method Preferences and Anticipated Stigma Among Female, Male, and Transgender Sex Workers in India
Location: Chicago 9

Primary Presenter: Anne E. Fehrenbacher, PhD, MPH – Department of Population and Public Health Sciences, University of Southern California

Behavioral & Social Science

Anne E. Fehrenbacher, PhD, MPH – Department of Population and Public Health Sciences, University of Southern California ### 1978136###Primary Presenter###Assistant Professor###Department of Population and Public Health Sciences, University of Southern California###
Primary Presenter: Anne E. Fehrenbacher, PhD, MPH – Department of Population and Public Health Sciences, University of Southern California
### @@@ Alexander Moran, Ph.D., M.S.P.H. – Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles ### 1978145###Co-author######Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles###
Co-author: Alexander Moran, Ph.D., M.S.P.H. – Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles
### @@@ Rajkumar Das – Balaram Dey Street Anandam ### 1978146###Co-author######Balaram Dey Street Anandam###
Co-author: Rajkumar Das – Balaram Dey Street Anandam
### @@@ Dipannita Mitra – Durbar Mahila Samanwaya Committee, Kolkata, West Bengal, India ### 1978147###Co-author######Durbar Mahila Samanwaya Committee, Kolkata, West Bengal, India###
Co-author: Dipannita Mitra – Durbar Mahila Samanwaya Committee, Kolkata, West Bengal, India
### @@@ Lokenath Bhattacharya – Durbar Mahila Samanwaya Committee ### 1978148###Co-author######Durbar Mahila Samanwaya Committee###
Co-author: Lokenath Bhattacharya – Durbar Mahila Samanwaya Committee
### @@@ Rama Samanta, M.A. – Durbar Mahila Samanwaya Committee ### 1978149###Co-author######Durbar Mahila Samanwaya Committee###
Co-author: Rama Samanta, M.A. – Durbar Mahila Samanwaya Committee
### @@@ Suchith Kumar – SK Professional Translation and Transcription Services, Mysore, Karnataka, India ### 1978157###Co-author######SK Professional Translation and Transcription Services, Mysore, Karnataka, India###
Co-author: Suchith Kumar – SK Professional Translation and Transcription Services, Mysore, Karnataka, India
### @@@ Ronald Brooks, Ph.D. – University of California, Los Angeles ### 1978151###Co-author######University of California, Los Angeles###
Co-author: Ronald Brooks, Ph.D. – University of California, Los Angeles
### @@@ Protim Ray, M.B.B.S. – Durbar Mahila Samanwaya Committee, Kolkata, West Bengal, India ### 1978153###Co-author######Durbar Mahila Samanwaya Committee, Kolkata, West Bengal, India###
Co-author: Protim Ray, M.B.B.S. – Durbar Mahila Samanwaya Committee, Kolkata, West Bengal, India
### @@@ Dallas Swendeman, Ph.D., MPH – Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles ### 1978156###Co-author######Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles###
Co-author: Dallas Swendeman, Ph.D., MPH – Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles
###

14:45 – 15:00 CST

O5.2 - THE ACCEPTABILITY OF PHARMACY-DELIVERED PREP IN KENYA: PROVIDER AND CLIENT PERCEPTIONS
Location: Chicago 9

Primary Presenter: Magdaline Asewe, n/a – Kenya Medical Research Institute

Implementation Science

Magdaline Asewe, n/a – Kenya Medical Research Institute ### 1978433###Primary Presenter###Data Quality Officer###Kenya Medical Research Institute###
Primary Presenter: Magdaline Asewe, n/a – Kenya Medical Research Institute
### @@@ Peter Mogere – PHRD ### 1978434###Co-author######PHRD###
Co-author: Peter Mogere – PHRD
### @@@ Benn Kwach – KEMRI- ### 1978435###Co-author######KEMRI-###
Co-author: Benn Kwach – KEMRI-
### @@@ Shengruo Zhang – University of Washington ### 1977978###Co-author######University of Washington###
Co-author: Shengruo Zhang – University of Washington
### @@@ Alexandra Kuo – University of Washington ### 1978436###Co-author######University of Washington###
Co-author: Alexandra Kuo – University of Washington
### @@@ Kendall Harkey – Fred Hutchinson cancer research center ### 1977980###Co-author######Fred Hutchinson cancer research center###
Co-author: Kendall Harkey – Fred Hutchinson cancer research center
### @@@ Stephen Gakuo – PHRD ### 1978437###Co-author######PHRD###
Co-author: Stephen Gakuo – PHRD
### @@@ Greshon Rota – KEMRI ### 1978438###Co-author######KEMRI###
Co-author: Greshon Rota – KEMRI
### @@@ Peris Otieno – KEMRI ### 1977979###Co-author######KEMRI###
Co-author: Peris Otieno – KEMRI
### @@@ Josephine Odoyo – KEMRI ### 1977981###Co-author######KEMRI###
Co-author: Josephine Odoyo – KEMRI
### @@@ Patricia Ongwen – JHPIEGO ### 1977982###Co-author######JHPIEGO###
Co-author: Patricia Ongwen – JHPIEGO
### @@@ Daniel Were – JHPIEGO ### 1977983###Co-author######JHPIEGO###
Co-author: Daniel Were – JHPIEGO
### @@@ Stephanie Roche – Fred Hutchinson cancer research center ### 1977984###Co-author######Fred Hutchinson cancer research center###
Co-author: Stephanie Roche – Fred Hutchinson cancer research center
### @@@ Victor Omollo, MBChB, MPH – Kenya Medical Research Institute ### 1977986###Co-author######Kenya Medical Research Institute###
Co-author: Victor Omollo, MBChB, MPH – Kenya Medical Research Institute
### @@@ Jared M. Baeten, MD, PhD – University of Washington and Gilead Inc ### 1978289###Co-author######University of Washington and Gilead Inc###
Co-author: Jared M. Baeten, MD, PhD – University of Washington and Gilead Inc
### @@@ Elizabeth Bukusi, MBChB, MMED, MPH, PhD – Kenya Medical Research Institute ### 1977987###Co-author######Kenya Medical Research Institute###
Co-author: Elizabeth Bukusi, MBChB, MMED, MPH, PhD – Kenya Medical Research Institute
### @@@ Kenneth Ngure – JKUAT ### 1977985###Co-author######JKUAT###
Co-author: Kenneth Ngure – JKUAT
### @@@ Katrina Ortblad – Fred Hutchinson cancer research center ### 1977988###Co-author######Fred Hutchinson cancer research center###
Co-author: Katrina Ortblad – Fred Hutchinson cancer research center
###

15:00 – 15:15 CST

O5.3 - Concordance between self-reported PrEP use using a diary app and intracellular tenofovir diphosphate in the Amsterdam PrEP demonstration project
Location: Chicago 9

Primary Presenter: Eline S. Wijstma (she/her/hers) – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands

Primary Presenter: Maarten Schim van der Loeff – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC location University of Amsterdam, Department of Infectious Diseases, Amsterdam Institute for Infection & Immunity (AII), Amsterdam, the Netherlands.

Epidemiology & Monitoring

Eline S. Wijstma (she/her/hers) – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands ### 1978479###Primary Presenter###PhD Student###Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands###
Primary Presenter: Eline S. Wijstma (she/her/hers) – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands
### she/her/hers @@@ Vita Jongen – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands ### 1978359###Co-author######Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands###
Co-author: Vita Jongen – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands
### @@@ Mark van den Elshout – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands ### 1978480###Co-author######Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands###
Co-author: Mark van den Elshout – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands
### @@@ Henry de Vries, Md PhD – Public Health Service Amsterdam and Amsterdam University Medical Centre ### 1978474###Co-author###dermatologist###Public Health Service Amsterdam and Amsterdam University Medical Centre###
Co-author: Henry de Vries, Md PhD – Public Health Service Amsterdam and Amsterdam University Medical Centre
### @@@ Udi Davidovich – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Department of Social Psychology, University of Amsterdam, Amsterdam, Netherlands ### 1978482###Co-author######Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Department of Social Psychology, University of Amsterdam, Amsterdam, Netherlands###
Co-author: Udi Davidovich – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Department of Social Psychology, University of Amsterdam, Amsterdam, Netherlands
### @@@ Maria Prins – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC location University of Amsterdam, Department of Infectious Diseases, Amsterdam Institute for Infection & Immunity (AII), Amsterdam, the Netherlands. ### 1978346###Co-author######Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC location University of Amsterdam, Department of Infectious Diseases, Amsterdam Institute for Infection & Immunity (AII), Amsterdam, the Netherlands.###
Co-author: Maria Prins – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC location University of Amsterdam, Department of Infectious Diseases, Amsterdam Institute for Infection & Immunity (AII), Amsterdam, the Netherlands.
### @@@ Elske Hoornenborg – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands ### 1978355###Co-author######Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands###
Co-author: Elske Hoornenborg – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands
### @@@ Maarten Schim van der Loeff – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC location University of Amsterdam, Department of Infectious Diseases, Amsterdam Institute for Infection & Immunity (AII), Amsterdam, the Netherlands. ### 1978363###Primary Presenter######Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC location University of Amsterdam, Department of Infectious Diseases, Amsterdam Institute for Infection & Immunity (AII), Amsterdam, the Netherlands.###
Primary Presenter: Maarten Schim van der Loeff – Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC location University of Amsterdam, Department of Infectious Diseases, Amsterdam Institute for Infection & Immunity (AII), Amsterdam, the Netherlands.
###

15:15 – 15:30 CST

O5.4 - Age patterns of HSV-2 incidence and prevalence in two communities in Rakai, Uganda: a catalytic incidence model applied to population-based seroprevalence data
Location: Chicago 9

Primary Presenter: Lilith K. Whittles, PhD (she/her/hers) – Imperial College London

Epidemiology & Monitoring

Lilith K. Whittles, PhD (she/her/hers) – Imperial College London ### 1977974###Primary Presenter###Sir Henry Wellcome Postdoctoral Fellow###Imperial College London###
Primary Presenter: Lilith K. Whittles, PhD (she/her/hers) – Imperial College London
### she/her/hers @@@ Ronald M. Galiwango – Rakai Health Sciences Program, Kalisizo, Uganda ### 1978003###Co-author######Rakai Health Sciences Program, Kalisizo, Uganda###
Co-author: Ronald M. Galiwango – Rakai Health Sciences Program, Kalisizo, Uganda
### @@@ Josephine Mpagazi – Rakai Health Sciences Program, Kalisizo, Uganda ### 1978004###Co-author######Rakai Health Sciences Program, Kalisizo, Uganda###
Co-author: Josephine Mpagazi – Rakai Health Sciences Program, Kalisizo, Uganda
### @@@ Aaron AR Tobian – Department of Pathology, Johns Hopkins School of Medicine; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD ### 1978005###Co-author######Department of Pathology, Johns Hopkins School of Medicine; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD###
Co-author: Aaron AR Tobian – Department of Pathology, Johns Hopkins School of Medicine; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
### @@@ Robert Ssekubugu – Rakai Health Sciences Program, Kalisizo, Uganda ### 1978006###Co-author######Rakai Health Sciences Program, Kalisizo, Uganda###
Co-author: Robert Ssekubugu – Rakai Health Sciences Program, Kalisizo, Uganda
### @@@ Jade Jackson – Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD ### 1978007###Co-author######Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD###
Co-author: Jade Jackson – Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD
### @@@ Austin D. Peer – Johns Hopkins University School of Medicine, Baltimore, MD ### 1978008###Co-author######Johns Hopkins University School of Medicine, Baltimore, MD###
Co-author: Austin D. Peer – Johns Hopkins University School of Medicine, Baltimore, MD
### @@@ Caitlin Kennedy – Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD ### 1978009###Co-author######Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD###
Co-author: Caitlin Kennedy – Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
### @@@ Margaret Nakalanzi – Rakai Health Sciences Program, Kalisizo, Uganda ### 1978010###Co-author######Rakai Health Sciences Program, Kalisizo, Uganda###
Co-author: Margaret Nakalanzi – Rakai Health Sciences Program, Kalisizo, Uganda
### @@@ Anthony Ndyanabo – Rakai Health Sciences Program, Kalisizo, Uganda ### 1978011###Co-author######Rakai Health Sciences Program, Kalisizo, Uganda###
Co-author: Anthony Ndyanabo – Rakai Health Sciences Program, Kalisizo, Uganda
### @@@ Godfrey Kigozi – Rakai Health Sciences Program, Kalisizo, Uganda ### 1978012###Co-author######Rakai Health Sciences Program, Kalisizo, Uganda###
Co-author: Godfrey Kigozi – Rakai Health Sciences Program, Kalisizo, Uganda
### @@@ Larry W. Chang – Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Department of International Health, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore, MD ### 1978013###Co-author######Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Department of International Health, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore, MD###
Co-author: Larry W. Chang – Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Department of International Health, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore, MD
### @@@ David Serwadda – Rakai Health Sciences Program, Kalisizo; Department of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda ### 1978014###Co-author######Rakai Health Sciences Program, Kalisizo; Department of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda###
Co-author: David Serwadda – Rakai Health Sciences Program, Kalisizo; Department of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda
### @@@ Yukari C. Manabe, MD – Department of Medicine, Johns Hopkins University, Baltimore, MD ### 1978015###Co-author######Department of Medicine, Johns Hopkins University, Baltimore, MD###
Co-author: Yukari C. Manabe, MD – Department of Medicine, Johns Hopkins University, Baltimore, MD
### @@@ Charlotte A. Gaydos, BS, MS, MPH, DrPH – Johns Hopkins University ### 1978016###Co-author###Professor###Johns Hopkins University###
Co-author: Charlotte A. Gaydos, BS, MS, MPH, DrPH – Johns Hopkins University
### @@@ Oliver Laeyendecker, Ph.D. – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore; Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD ### 1978017###Co-author######Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore; Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD###
Co-author: Oliver Laeyendecker, Ph.D. – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore; Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
### @@@ Thomas C. Quinn – Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore; 9 Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD ### 1978018###Co-author######Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore; 9 Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD###
Co-author: Thomas C. Quinn – Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore; 9 Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
### @@@ Steven J. Reynolds – Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore; 9 Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD ### 1978019###Co-author######Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore; 9 Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD###
Co-author: Steven J. Reynolds – Rakai Health Sciences Program, Kalisizo, Uganda; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Department of Medicine, Johns Hopkins University, Baltimore; 9 Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
### @@@ Joseph Kagaayi – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Department of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda ### 1978020###Co-author######Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Department of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda###
Co-author: Joseph Kagaayi – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Department of Disease Control and Environmental Health, Makerere University School of Public Health, Kampala, Uganda
### @@@ Jeffrey W. Eaton, PhD – MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London ### 1978021###Co-author###Reader in Epidemiology, Demography, and Applied Statistics###MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London###
Co-author: Jeffrey W. Eaton, PhD – MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London
### @@@ M Kate Grabowski – Johns Hopkins University ### 1978022###Co-author######Johns Hopkins University###
Co-author: M Kate Grabowski – Johns Hopkins University
###

15:30 – 15:45 CST

O5.5 - Pritelivir for the treatment of resistant HSV infections in immunocompromised patients: update on an ongoing Phase 3 trial and Early Access Program
Location: Chicago 9

Primary Presenter: Alexander Birkmann, PhD – AiCuris Anti-Infective Cures AG

Clinical Science

15:45 – 16:00 CST

O5.6 - Knowledge and acceptability of Human Papillomavirus vaccination for young adult women in rural Mysore District, India: a qualitative study
Location: Chicago 9

Primary Presenter: Kate Coursey (she/her/hers) – David Geffen School of Medicine at UCLA

Behavioral & Social Science

Kate Coursey (she/her/hers) – David Geffen School of Medicine at UCLA ### 1978215###Primary Presenter###Medical Student###David Geffen School of Medicine at UCLA###
Primary Presenter: Kate Coursey (she/her/hers) – David Geffen School of Medicine at UCLA
### she/her/hers @@@ Kiranmayee Muralidhar – Public Health Research Institute of India ### 1978216###Co-author######Public Health Research Institute of India###
Co-author: Kiranmayee Muralidhar – Public Health Research Institute of India
### @@@ Vijaya Srinivas – Public Health Research Institute of India ### 1978217###Co-author######Public Health Research Institute of India###
Co-author: Vijaya Srinivas – Public Health Research Institute of India
### @@@ Poornima Jaykrishna – Public Health Research Institute of India ### 1978218###Co-author######Public Health Research Institute of India###
Co-author: Poornima Jaykrishna – Public Health Research Institute of India
### @@@ Fazila Begum – Public Health Research Institute of India ### 1978219###Co-author######Public Health Research Institute of India###
Co-author: Fazila Begum – Public Health Research Institute of India
### @@@ Rashmi Pramathesh – Public Health Research Institute of India ### 1978220###Co-author######Public Health Research Institute of India###
Co-author: Rashmi Pramathesh – Public Health Research Institute of India
### @@@ Sung-Jae Lee – UCLA Nathanson Family Resilience Center, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles ### 1978221###Co-author######UCLA Nathanson Family Resilience Center, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles###
Co-author: Sung-Jae Lee – UCLA Nathanson Family Resilience Center, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles
### @@@ Purnima Madhivanan – Mel & Enid Zuckerman College of Public Health, University of Arizona ### 1978222###Co-author######Mel & Enid Zuckerman College of Public Health, University of Arizona###
Co-author: Purnima Madhivanan – Mel & Enid Zuckerman College of Public Health, University of Arizona
###

14:30 – 16:00 CST

Biomedical prevention for STIs and HIV
Location: Chicago 10

Moderator: Marc Steben

Moderator: Sebastian S. Fuller, PhD (he/him/his) – University of Oxford

14:30 – 14:45 CST

O6.1 - High uptake of Doxycycline for STI prevention (doxy-PEP) among individuals using HIV PrEP at a municipal sexual health clinic in San Francisco, California
Location: Chicago 10

Primary Presenter: Oliver Bacon, MD MPH (he/him/his) – San Francisco City Clinic, San Francisco Department of Public Health

Implementation Science

14:45 – 15:00 CST

O6.2 - Syphilis testing, incidence, and reinfection among gay and bisexual men with and without HIV in Australia over a decade spanning HIV PrEP implementation
Location: Chicago 10

Primary Presenter: Michael W. Traeger, PhD (he/him/his) – Burnet Institute

Epidemiology & Monitoring

Michael W. Traeger, PhD (he/him/his) – Burnet Institute ### 1978075###Primary Presenter###Research Fellow###Burnet Institute###
Primary Presenter: Michael W. Traeger, PhD (he/him/his) – Burnet Institute
### he/him/his @@@ Rebecca Guy – Kirby Institute ### 1978223###Co-author######Kirby Institute###
Co-author: Rebecca Guy – Kirby Institute
### @@@ Caroline Taunton – Burnet Institute ### 1978224###Co-author######Burnet Institute###
Co-author: Caroline Taunton – Burnet Institute
### @@@ Eric P.F Chow, PhD, MScMed(ClinEpid), MBiostat, MPH, MApplSc (he/him/his) – Monash University ### 1977877###Co-author###Professor###Monash University###
Co-author: Eric P.F Chow, PhD, MScMed(ClinEpid), MBiostat, MPH, MApplSc (he/him/his) – Monash University
### he/him/his @@@ Jason Asselin – Burnet Institute ### 1978225###Co-author######Burnet Institute###
Co-author: Jason Asselin – Burnet Institute
### @@@ Allison Carter – Kirby Institute ### 1978226###Co-author######Kirby Institute###
Co-author: Allison Carter – Kirby Institute
### @@@ Mark Bloch – Holdsworth House Medical Centre ### 1978227###Co-author######Holdsworth House Medical Centre###
Co-author: Mark Bloch – Holdsworth House Medical Centre
### @@@ Christopher K. Fairley – Melbourne Sexual Health Centre, Alfred Health ### 1977878###Co-author######Melbourne Sexual Health Centre, Alfred Health###
Co-author: Christopher K. Fairley – Melbourne Sexual Health Centre, Alfred Health
### @@@ Anna McNulty – Sydney Sexual Health Centre ### 1978228###Co-author######Sydney Sexual Health Centre###
Co-author: Anna McNulty – Sydney Sexual Health Centre
### @@@ Vincent Cornelisse – Kirketon Road Centre ### 1978229###Co-author######Kirketon Road Centre###
Co-author: Vincent Cornelisse – Kirketon Road Centre
### @@@ Phillip Read – Kirketon Road Centre ### 1978230###Co-author######Kirketon Road Centre###
Co-author: Phillip Read – Kirketon Road Centre
### @@@ Louise Owen – Statewide Sexual Health Service, Tasmania ### 1978231###Co-author######Statewide Sexual Health Service, Tasmania###
Co-author: Louise Owen – Statewide Sexual Health Service, Tasmania
### @@@ Nathan Ryder, MBBS, MPHTM – Hunter New England Sexual Health ### 1977895###Co-author###Clinical Director Sexual Health###Hunter New England Sexual Health###
Co-author: Nathan Ryder, MBBS, MPHTM – Hunter New England Sexual Health
### @@@ David Templeton – Kirby Institute ### 1978232###Co-author######Kirby Institute###
Co-author: David Templeton – Kirby Institute
### @@@ Darryl O'Donnell – Australian Federation of AIDS Organisations ### 1978233###Co-author######Australian Federation of AIDS Organisations###
Co-author: Darryl O'Donnell – Australian Federation of AIDS Organisations
### @@@ Basil Donovan, MD – Kirby Institute, UNSW Sydney ### 1977892###Co-author###Professor###Kirby Institute, UNSW Sydney###
Co-author: Basil Donovan, MD – Kirby Institute, UNSW Sydney
### @@@ Margaret Hellard – Burnet Institute ### 1978234###Co-author######Burnet Institute###
Co-author: Margaret Hellard – Burnet Institute
### @@@ Mark Stoové – Burnet Institute ### 1978235###Co-author######Burnet Institute###
Co-author: Mark Stoové – Burnet Institute
###

15:00 – 15:15 CST

O6.3 - Self-reported adherence to event-driven doxycycline postexposure prophylaxis for sexually transmitted infection prevention among cisgender women
Location: Chicago 10

Primary Presenter: Jenell Stewart, DO, MPH (she/her/hers) – Hennepin Healthcare Research Institute and University of Minnesota

Behavioral & Social Science

Jenell Stewart, DO, MPH (she/her/hers) – Hennepin Healthcare Research Institute and University of Minnesota ### 1878828###Primary Presenter###Assistant Professor###Hennepin Healthcare Research Institute and University of Minnesota###
Primary Presenter: Jenell Stewart, DO, MPH (she/her/hers) – Hennepin Healthcare Research Institute and University of Minnesota
### she/her/hers @@@ Kevin Oware, MA – Kenya Medical Research Institute ### 1978282###Co-author######Kenya Medical Research Institute###
Co-author: Kevin Oware, MA – Kenya Medical Research Institute
### @@@ Deborah Donnell, PhD – Fred Hutchinson Cancer Center ### 1978283###Co-author######Fred Hutchinson Cancer Center###
Co-author: Deborah Donnell, PhD – Fred Hutchinson Cancer Center
### @@@ Lauren R. Violette, MPH – Departments of Medicine and Epidemiology, University of Washington ### 1978284###Co-author######Departments of Medicine and Epidemiology, University of Washington###
Co-author: Lauren R. Violette, MPH – Departments of Medicine and Epidemiology, University of Washington
### @@@ Josephine Odoyo – KEMRI ### 1977981###Co-author######KEMRI###
Co-author: Josephine Odoyo – KEMRI
### @@@ Jane Simoni, PhD – Department of Psychology ### 1978287###Co-author######Department of Psychology###
Co-author: Jane Simoni, PhD – Department of Psychology
### @@@ Victor Omollo, MBChB, MPH – Kenya Medical Research Institute ### 1977986###Co-author######Kenya Medical Research Institute###
Co-author: Victor Omollo, MBChB, MPH – Kenya Medical Research Institute
### @@@ Felix Ong'era Mogaka, MBChB (he/him/his) – Kenya Medical Research Institute ### 1878827###Co-author###Research Scientist###Kenya Medical Research Institute###
Co-author: Felix Ong'era Mogaka, MBChB (he/him/his) – Kenya Medical Research Institute
### he/him/his @@@ Elizabeth Bukusi, MBChB, MMED, MPH, PhD – Kenya Medical Research Institute ### 1977987###Co-author######Kenya Medical Research Institute###
Co-author: Elizabeth Bukusi, MBChB, MMED, MPH, PhD – Kenya Medical Research Institute
### @@@ Jared M. Baeten, MD, PhD – University of Washington and Gilead Inc ### 1978289###Co-author######University of Washington and Gilead Inc###
Co-author: Jared M. Baeten, MD, PhD – University of Washington and Gilead Inc
###

15:15 – 15:30 CST

O6.4 - A genomic perspective on the near-term impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance
Location: Chicago 10

Primary Presenter: Tatum D. Mortimer, PhD (she/her/hers) – Harvard T.H. Chan School of Public Health

Epidemiology & Monitoring

15:30 – 15:45 CST

O6.5 - Discontinuation of Pre-Exposure Prophylaxis and associated factors among Female Commercial Sex Workers attending the most at-risk population clinic, Mulago Hospital, Uganda
Location: Chicago 10

Primary Presenter: Racheal Naturinda, Masters of Health Services Research – Makerere University School of Public Health

Behavioral & Social Science

15:45 – 16:00 CST

O6.6 - PrEP outcomes and sexual health in China during COVID-19 lockdowns
Location: Chicago 10

Primary Presenter: Chunyan Li, PhD – Tokyo College, University of Tokyo; University of North Carolina Project China

Behavioral & Social Science

Chunyan Li, PhD – Tokyo College, University of Tokyo; University of North Carolina Project China ### 1978050###Primary Presenter###Postdoctoral Fellow###Tokyo College, University of Tokyo; University of North Carolina Project China###
Primary Presenter: Chunyan Li, PhD – Tokyo College, University of Tokyo; University of North Carolina Project China
### @@@ Zhuoheng Yin, MA – UNC Project China ### 1978049###Co-author###Research assistant###UNC Project China###
Co-author: Zhuoheng Yin, MA – UNC Project China
### @@@ Joseph D. Tucker – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK ### 1878788###Co-author######Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK###
Co-author: Joseph D. Tucker – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
### @@@ Songjie Wu – Wuhan Zhongnan Hospital ### 1978410###Co-author######Wuhan Zhongnan Hospital###
Co-author: Songjie Wu – Wuhan Zhongnan Hospital
### @@@ Haojie Huang – Wuhan Tongxing LGBT Center ### 1978053###Co-author######Wuhan Tongxing LGBT Center###
Co-author: Haojie Huang – Wuhan Tongxing LGBT Center
### @@@ Ke Liang – Zhongnan Hospital of Wuhan University ### 1978207###Co-author######Zhongnan Hospital of Wuhan University###
Co-author: Ke Liang – Zhongnan Hospital of Wuhan University
### @@@ Linghua Li – Guangzhou Eighth People's Hospital ### 1978051###Co-author######Guangzhou Eighth People's Hospital###
Co-author: Linghua Li – Guangzhou Eighth People's Hospital
### @@@ Wu Sun – Guangzhou Eighth People's Hospital ### 1978407###Co-author######Guangzhou Eighth People's Hospital###
Co-author: Wu Sun – Guangzhou Eighth People's Hospital
### @@@ Quanmin Li – Guangzhou Eighth People's Hospital ### 1978408###Co-author######Guangzhou Eighth People's Hospital###
Co-author: Quanmin Li – Guangzhou Eighth People's Hospital
### @@@ Jonathan Lio – University of Chicago ### 1978052###Co-author######University of Chicago###
Co-author: Jonathan Lio – University of Chicago
### @@@ Aniruddha Hazra, MD – University of Chicago ### 1977927###Co-author###Assistant Professor of Medicine###University of Chicago###
Co-author: Aniruddha Hazra, MD – University of Chicago
### @@@ Weiming Tang – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1977977###Co-author######Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Co-author: Weiming Tang – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
### @@@ Renslow Sherer, Jr. – University of Chicago ### 1978409###Co-author###Professor of Medicine###University of Chicago###
Co-author: Renslow Sherer, Jr. – University of Chicago
###

14:30 – 16:00 CST

Late Breaker 1: LGV, chlamydia and mpox
Location: Michigan A/B

14:30 – 14:45 CST

LB1.1 - Prevalence and epidemiology of Lymphogranuloma venereum in France, 2020-2022
Location: Michigan A+B

Primary Presenter: Cecile Bebear, MD PhD (she/her/hers) – Bordeaux University Hospital

Epidemiology & Monitoring

14:45 – 15:00 CST

LB1.2 - Genetic diversity of Chlamydia trachomatis infection among patients presenting with genital lesions in Malawi
Location: Michigan A+B

Primary Presenter: Christopher M. Hennelly, n/a – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

Epidemiology & Monitoring

Christopher M. Hennelly, n/a – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1978570###Primary Presenter######Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Primary Presenter: Christopher M. Hennelly, n/a – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
### @@@ Jane S. Chen, PhD – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1978116###Co-author######Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Co-author: Jane S. Chen, PhD – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
### @@@ Mitch M. Matoga, MD, MSc (he/him/his) – University of North Carolina Project Malawi, Lilongwe, Malawi ### 1978115###Co-author###Director of STI Research and Clinical Services###University of North Carolina Project Malawi, Lilongwe, Malawi###
Co-author: Mitch M. Matoga, MD, MSc (he/him/his) – University of North Carolina Project Malawi, Lilongwe, Malawi
### he/him/his @@@ Jenny Coelho – University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1978571###Co-author######University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Co-author: Jenny Coelho – University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
### @@@ Farhang Aghakhanian – Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina,USA ### 1978342###Co-author######Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina,USA###
Co-author: Farhang Aghakhanian – Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina,USA
### @@@ Justin D. Radolf – UConn Health, Farmington, Connecticut, USA; Connecticut Children’s, Hartford, Connecticut, USA ### 1978336###Co-author######UConn Health, Farmington, Connecticut, USA; Connecticut Children’s, Hartford, Connecticut, USA###
Co-author: Justin D. Radolf – UConn Health, Farmington, Connecticut, USA; Connecticut Children’s, Hartford, Connecticut, USA
### @@@ M. Anthony Moody, MD – Duke Human Vaccine Institute, Duke Univerity, Durham, North Carolina, USA ### 1978399###Co-author###Professor of Pediatrics and Immunology###Duke Human Vaccine Institute, Duke Univerity, Durham, North Carolina, USA###
Co-author: M. Anthony Moody, MD – Duke Human Vaccine Institute, Duke Univerity, Durham, North Carolina, USA
### @@@ Toni Darville – University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1978572###Co-author######University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Co-author: Toni Darville – University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
### @@@ Jonathan J. Juliano – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1978401###Co-author######Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Co-author: Jonathan J. Juliano – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
### @@@ Catherine O'Connell – University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1978573###Co-author######University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Co-author: Catherine O'Connell – University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
### @@@ Arlene C. Seña, MD, MPH – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1978027###Co-author###Professor of Medicine###Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Co-author: Arlene C. Seña, MD, MPH – Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
### @@@ Irving Hoffman, MPH – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1978120###Co-author###Professor of Medicine###Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Co-author: Irving Hoffman, MPH – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
### @@@ Jonathan B. Parr, MD, MPH – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1978119###Co-author###Assistant Professor of Medicine###Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Co-author: Jonathan B. Parr, MD, MPH – Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
###

15:00 – 15:15 CST

LB1.3 - Evaluating immunological responses of mRNA-based Chlamydia vaccines
Location: Michigan A+B

Primary Presenter: Wei He, n/a – Lawrence Livermore National Laboratory

Basic & Translational Science

Wei He, n/a – Lawrence Livermore National Laboratory ### 1978579###Primary Presenter###Biomedical Scientist###Lawrence Livermore National Laboratory###
Primary Presenter: Wei He, n/a – Lawrence Livermore National Laboratory
### @@@ Amy Rasley – Lawrence LIvermore National Laboratory ### 1978581###Co-author######Lawrence LIvermore National Laboratory###
Co-author: Amy Rasley – Lawrence LIvermore National Laboratory
### @@@ Sandra Peters – Lawrence LIvermore National Laboratory ### 1978582###Co-author######Lawrence LIvermore National Laboratory###
Co-author: Sandra Peters – Lawrence LIvermore National Laboratory
### @@@ Dina Weilhammer – Lawrence LIvermore National Laboratory ### 1978583###Co-author######Lawrence LIvermore National Laboratory###
Co-author: Dina Weilhammer – Lawrence LIvermore National Laboratory
### @@@ Abisola Abisoye-Ogunniyan – Lawrence LIvermore National Laboratory ### 1978584###Co-author######Lawrence LIvermore National Laboratory###
Co-author: Abisola Abisoye-Ogunniyan – Lawrence LIvermore National Laboratory
### @@@ Feliza Bourguet – Lawrence LIvermore National Laboratory ### 1978588###Co-author######Lawrence LIvermore National Laboratory###
Co-author: Feliza Bourguet – Lawrence LIvermore National Laboratory
### @@@ Dominique Hall – Lawrence LIvermore National Laboratory ### 1978589###Co-author######Lawrence LIvermore National Laboratory###
Co-author: Dominique Hall – Lawrence LIvermore National Laboratory
### @@@ Sukumar Pal – Department of Pathology and Laboratory Medicine, University of California Irvine ### 1978590###Co-author######Department of Pathology and Laboratory Medicine, University of California Irvine###
Co-author: Sukumar Pal – Department of Pathology and Laboratory Medicine, University of California Irvine
### @@@ Luis de la Maza – Department of Pathology and Laboratory Medicine, University of California Irvine ### 1978591###Co-author######Department of Pathology and Laboratory Medicine, University of California Irvine###
Co-author: Luis de la Maza – Department of Pathology and Laboratory Medicine, University of California Irvine
### @@@ Toni Darville – University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA ### 1978572###Co-author######University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA###
Co-author: Toni Darville – University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
### @@@ Nicholas Fischer – Lawrence LIvermore National Laboratory ### 1978592###Co-author######Lawrence LIvermore National Laboratory###
Co-author: Nicholas Fischer – Lawrence LIvermore National Laboratory
### @@@ Matthew Coleman – Lawrence LIvermore National Laboratory ### 1978593###Co-author######Lawrence LIvermore National Laboratory###
Co-author: Matthew Coleman – Lawrence LIvermore National Laboratory
###

15:15 – 15:30 CST

LB1.4 - Mpox resurgence in 2023 in Toronto, Canada – surveillance and vaccine approaches
Location: Michigan A+B

Primary Presenter: Sylvia Ota, MHSc (she/her/hers) – Toronto Public Health

Co-Author: Rita Shahin, n/a – Toronto Public Health

Epidemiology & Monitoring

15:30 – 15:45 CST

LB1.5 - Modelling the impact of vaccination and sexual behavior adaptation on reported cases of mpox in Washington D.C.
Location: Michigan A+B

Primary Presenter: Patrick A. Clay, PhD (he/him/his) – Centers for Disease Control and Prevention

Epidemiology & Monitoring

Patrick A. Clay, PhD (he/him/his) – Centers for Disease Control and Prevention ### 1978525###Primary Presenter###Health Scientist###Centers for Disease Control and Prevention###
Primary Presenter: Patrick A. Clay, PhD (he/him/his) – Centers for Disease Control and Prevention
### he/him/his @@@ Jason M. Asher – Centers for Disease Control & Prevention ### 1978169###Co-author######Centers for Disease Control & Prevention###
Co-author: Jason M. Asher – Centers for Disease Control & Prevention
### @@@ Neal Carnes – Centers for Disease Control and Prevention ### 1978526###Co-author######Centers for Disease Control and Prevention###
Co-author: Neal Carnes – Centers for Disease Control and Prevention
### @@@ Casey E. Copen – Centers for Disease Control and Prevention ### 1978527###Co-author######Centers for Disease Control and Prevention###
Co-author: Casey E. Copen – Centers for Disease Control and Prevention
### @@@ Kevin P. Delaney, PhD MPH – Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention ### 1978301###Co-author######Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention###
Co-author: Kevin P. Delaney, PhD MPH – Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
### @@@ Daniel C. Payne – Centers for Disease Control and Prevention ### 1978528###Co-author######Centers for Disease Control and Prevention###
Co-author: Daniel C. Payne – Centers for Disease Control and Prevention
### @@@ Emily D. Pollock, PhD (she/her/hers) – Centers for Disease Control & Prevention ### 1978167###Co-author###Prevention Effectiveness Fellow###Centers for Disease Control & Prevention###
Co-author: Emily D. Pollock, PhD (she/her/hers) – Centers for Disease Control & Prevention
### she/her/hers @@@ Jonathan Mermin – Centers for Disease Control and Prevention ### 1978529###Co-author######Centers for Disease Control and Prevention###
Co-author: Jonathan Mermin – Centers for Disease Control and Prevention
### @@@ Yoshinori Nakazawa – Centers for Disease Control & Prevention ### 1978168###Co-author######Centers for Disease Control & Prevention###
Co-author: Yoshinori Nakazawa – Centers for Disease Control & Prevention
### @@@ William Still – DC Public Health ### 1978530###Co-author######DC Public Health###
Co-author: William Still – DC Public Health
### @@@ Anil Mangla – DC Public Health ### 1977943###Co-author######DC Public Health###
Co-author: Anil Mangla – DC Public Health
### @@@ Ian Spicknall – Centers for Disease Control & Prevention ### 1977931###Co-author######Centers for Disease Control & Prevention###
Co-author: Ian Spicknall – Centers for Disease Control & Prevention
###

15:45 – 16:00 CST

LB1.6 - Modeling potential mpox resurgence among gay, bisexual, and other men who have sex with men in Washington, DC.
Location: Michigan A+B

Primary Presenter: Emily D. Pollock, PhD (she/her/hers) – Centers for Disease Control & Prevention

Epidemiology & Monitoring

14:30 – 16:00 CST

STI guidelines
Location: Sheraton Ballroom

Moderator: Claire Dewsnap

Moderator: Laura H. Bachmann, MD, MPH (she/her/hers) – Centers for Disease Control/DSTDP

Invited Talk

14:35 – 14:55 CST

SP2.1 - Why are there differences in our guidelines?
Location: Sheraton Ballroom

Invited Speaker: Kimberly Workowski, MD – Emory University

Invited Talk

14:55 – 15:15 CST

SP2.2 - Addressing trans and non-binary health in guidelines
Location: Sheraton Ballroom

Invited Speaker: Asa Radix, MD PhD (they/them/theirs) – Callen-Lorde Community Health Center

Invited Talk

15:15 – 15:35 CST

SP2.3 - Living guidelines - what does good look like?
Location: Sheraton Ballroom

Invited Speaker: Jackie Sherrard, MD – Bucks Healthcare NHS Trust

Invited Talk

14:30 – 16:00 CST

Vaccines for STI prevention: development, acceptance and equity
Location: Chicago 6

Invited Talk

14:35 – 14:55 CST

SY3.1 - State of syphilis vaccine development
Location: Chicago 6

Invited Speaker: Lorenzo Giacani, PhD (he/him/his) – University of Washington

Invited Talk

14:55 – 15:15 CST

SY3.2 - State of vaccine development for Neisseria gonorrhoeae
Location: Chicago 6

Invited Speaker: Sanjay Ram, MBBS (he/him/his) – University of Massachusetts Chan Medical School

Invited Talk

15:15 – 15:35 CST

SY3.3 - State of chlamydia vaccine development
Location: Chicago 6

Invited Speaker: Alvaro Borges, MD, MSc, PhD (he/him/his) – Centre for Vaccine Research, Statens Serum Institut

Invited Talk

15:35 – 15:55 CST

SY3.4 - STI Vaccine Acceptance and Equity
Location: Chicago 6

Invited Speaker: Alison Footman, PhD (she/her/hers) – AVAC

Invited Talk

14:30 – 16:00 CST

Queer Theory & Intersectionality in STI Prevention and Care
Location: Chicago 7

Moderator: Bradley Stoner, MD, PhD – Queen's University

Moderator: Jackson Montgomery (he/him/his) – University of Chicago Medical Center

Invited Talk

14:35 – 14:55 CST

SY4.1 - Centering Sex Positivity in STI & HIV prevention
Location: Chicago 7

Invited Speaker: Ruth Morgan Thomas (she/her/hers) – RuthMorganThomas

Invited Talk

14:55 – 15:15 CST

SY4.2 - Community-Led Responses: Vital for Effective STI Interventions, Policy and Impact
Location: Chicago 7

Invited Speaker: Solange L. Baptiste, ScM (she/her/hers) – International Treatment Preparedness Coalition (ITPC)

Invited Talk

15:15 – 15:35 CST

SY4.3 - Chemsex and Sexualised Drug Use
Location: Chicago 7

Invited Speaker: Glenn-Milo Santos, PhD, MPH – University of California San Francisco

Invited Talk

15:35 – 15:55 CST

SY4.4 - Trans and non-binary sexual health
Location: Chicago 7

Invited Speaker: Olivia T. Van Gerwen, MD, MPH – Division of Infectious Diseases, University of Alabama at Birmingham

Invited Talk

16:00 – 17:00 CST

Invite Only: NIH Magi meeting
Location: Huron

16:00 – 18:00 CST

Advocacy Zone
Location: Exhibit Hall

16:00 – 18:00 CST

Invite Only: CDC STIIR Consortium
Location: Mayfair

16:00 – 18:00 CST

Poster Session
Location: Riverwalk A/B

16:30 – 18:00 CST

Atlas of Queer Anatomy Workshop - Sign up Requested
Location: Erie

Invited Speaker: Henry de Vries, Md PhD – Public Health Service Amsterdam and Amsterdam University Medical Centre